Of note, as C5aRA could reverse some of pathology and CD4+T cells immune changes in RSV-infected asthma mice, C5a-C5aR may represent a potential therapeutic target in the treatment of this condition, and the further underlying mechnisms demand more exploration. Here, CD4 is linked to asthma.